Pluripotency and nuclear reprogramming
- PMID: 18375377
- PMCID: PMC2610180
- DOI: 10.1098/rstb.2008.2261
Pluripotency and nuclear reprogramming
Abstract
Embryonic stem cells are promising donor cell sources for cell transplantation therapy, which may in the future be used to treat various diseases and injuries. However, as is the case for organ transplantation, immune rejection after transplantation is a potential problem with this type of therapy. Moreover, the use of human embryos presents serious ethical difficulties. These issues may be overcome if pluripotent stem cells are generated from patients' somatic cells. Here, we review the molecular mechanisms underlying pluripotency and the currently known methods of inducing pluripotency in somatic cells.
Figures
References
-
- Adhikary S, Eilers M. Transcriptional regulation and transformation by Myc proteins. Nat. Rev. Mol. Cell Biol. 2005;6:635–645. doi:10.1038/nrm1703 - DOI - PubMed
-
- Aubert J, Dunstan H, Chambers I, Smith A. Functional gene screening in embryonic stem cells implicates Wnt antagonism in neural differentiation. Nat. Biotechnol. 2002;20:1240–1245. doi:10.1038/nbt763 - DOI - PubMed
-
- Auernhammer C.J, Melmed S. Leukemia-inhibitory factor-neuroimmune modulator of endocrine function. Endocr. Rev. 2000;21:313–345. doi:10.1210/er.21.3.313 - DOI - PubMed
-
- Avilion A.A, Nicolis S.K, Pevny L.H, Perez L, Vivian N, Lovell-Badge R. Multipotent cell lineages in early mouse development depend on Sox2 function. Genes Dev. 2003;17:126–140. doi:10.1101/gad.224503 - DOI - PMC - PubMed
-
- Baguisi A, et al. Production of goats by somatic cell nuclear transfer. Nat. Biotechnol. 1999;17:456–461. doi:10.1038/8632 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources